Antineoplastic/atezolizumabGrade 4 neutropenia, grade 2 dysesthesia and fulminant myocarditis

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2003卷 / 1期

关键词：

D O I：

10.1007/s40278-024-55922-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] The development of grade 3 or 4 neutropenia during antineoplastic therapy
Reactions Weekly, 1999, 743 (1) : 4 - 4
[2] Ipilimumab/NivolumabCutaneous irAE grade 2, hepaotoxic irAE grade and fatal fulminant myocarditis: case report
Reactions Weekly, 2025, 2046 (1) : 210 - 210
[3] Eribulin/trastuzumabFebrile neutropenia and grade-4 neutropenia: 2 case reports
Reactions Weekly, 2021, 1843 (1) : 155 - 155
[4] PembrolizumabMyocarditis and fulminant myocarditis: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 338 - 338
[5] AntineoplasticsLack of efficacy and Grade 4 neutropenia
Reactions Weekly, 2024, 1989 (1) : 31 - 31
[6] LinezolidGrade 3 anaemia and grade 4 neutropenia: 2 case reports
Reactions Weekly, 2023, 1981 (1) : 229 - 229
[7] Multiple drugsLack of efficacy and fulminant myocarditis: 4 case reports
Reactions Weekly, 2025, 2049 (1) : 253 - 253
[8] Azacitidine/venetoclaxGrade 4 neutropenia, grade 2 thrombocytopenia and grade 3 stomatitis : case report
Reactions Weekly, 2023, 1979 (1) : 78 - 78
[9] Fatal fulminant HSV-2 myocarditis: A complicated presentation
Colombo, Daniele
Albore, Marco
Del Nonno, Franca
Bolino, Giorgio
D'Ambrosio, Mario
Salvi, Alessandra
Cecannecchia, Camilla
Falasca, Laura
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 124 - 127
[10] Fulminant myocarditis as an early presentation of SARS-CoV-2
Naneishvili, Tamara
Khalil, Arsalan
O'Leary, Ryan
Prasad, Neeraj
BMJ CASE REPORTS, 2020, 13 (09)

← 1 2 3 4 5 →